[1] SUNG H,FERLAY J,SIEGEL RL,et al.Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J].CA Cancer J Clin,2021,71(3):209-249.
[2] YANG L,YING X,LIU S,et al.Gastric cancer:Epidemiology,risk factors and prevention strategies [J].Chin J Cancer Res,2020,32(6):695-704.
[3] HUANG Z,ZHANG Z,ZHOU C,et al.Epithelial-mesenchymal transition:The history,regulatory mechanism,and cancer therapeutic opportunities [J].Med Comm,2022,3(2):e144.
[4] VILLALONGA E,MOSRIN C,NORMAND T,et al.LIM kinases,LIMK1 and LIMK2,are crucial node actors of the cell fate:molecular to pathological features [J].Cells,2023,12(5):805.
[5] RIBBA AS,FRABOULET S,SADOUL K,et al.The role of LIM kinases during development:a lens to get a glimpse of their implication in pathologies [J].Cells,2022,11(3):403.
[6] MITRA S,DAS R,EMRAN TB,et al.Diallyl disulfide:a bioactive garlic compound with anticancer potential[J].Front Pharmacol,2022,13:943967.
[7] SONG X,YUE Z,NIE L,et al.Biological functions of Diallyl disulfide,a garlic-derived natural organic sulfur compound [J].Evid Based Complement Alternat Med,2021,2021:5103626.
[8] SU B,SU J,HE H,et al.Identification of potential targets for diallyl disulfide in human gastric cancer MGC-803 cells using proteomics approaches [J].Oncol Rep,2015,33(5):2484-2494.
[9] 何慧,马艳华,苏波,等.二烯丙基二硫对人胃癌MGC803细胞Rac1-Pak1/Rock1通路的影响[J].中国药理学通报,2014,30(3):349-354.
HE H,MA YH,SU B,et al.Effects of Diallyl disulfide on Rac1-Pak1/Rock1 pathway in human gastric cancer MGC803 cells[J].Chin Pharmacol Bul,2014,30(3):349-354.
[10] MA N,XU E,LUO Q,et al.Rac1:A regulator of cell migration and a potential target for cancer therapy[J].Molecules,2023,28(7):2976.
[11] BUDI HS,YOUNUS LA,LAFTA MH,et al.The role of miR-128 in cancer development,prevention,drug resistance,and immunotherapy [J].Front Oncol,2023,12:1067974.
[12] ZHANG S,SHI W,HU W,et al.DEP Domain-Containing Protein 1B(DEPDC1B) promotes migration and invasion in pancreatic cancer through the Rac1/PAK1-LIMK1-Cofilin1 signaling pathway[J].Onco Targets Ther,2020,13:1481-1496.
[13] WUFUER R,MA HX,LUO MY,et al.Downregulation of Rac1/PAK1/LIMK1/Cofilin signaling pathway in colon cancer SW620 cells treated with Chlorin e6 photodynamic therapy[J].Photodiagnosis Photodyn Ther,2021,33:102143.
[14] ZENG Y,REN M,LI YK,et al.Knockdown of RhoGDI2 represses human gastric cancer cell proliferation,invasion and drug resistance via the Rac1/Pak1/LIMK1 pathway[J].Cancer Lett,2020,492:136-146.
[15] GUO D,LI YR,CHEN DF,et al.Regulatory effects of LIM kinase 1 on the proliferation and metastasis of hepatocellular carcinoma cells[J].Chinese Journal of Liver,2021,29(5):427-432.
[16] SUN X,LI S,LIN H.LIMK1 interacts with STK25 to regulate EMT and promote the proliferation and metastasis of colorectal cancer [J].J Oncol,2022,2022:3963883.
[17] LI ZF,YAO YD,ZHAO YY,et al.Effects of PAK4/LIMK1/Cofilin-1 signaling pathway on proliferation,invasion,and migration of human osteosarcoma cells[J].J Clin Lab Anal,2020,34(9):e23362.
[18] 史玲,苏坚,孙晓勤,等.沉默LIMK1抑制人结肠癌SW480细胞上皮-间质转化[J].现代肿瘤医学,2020,28(13):2183-2188.
SHI L,SU J,SUN XQ,et al.Silencing LIMK1 inhibits epithelial-mesenchymal transformation of human colon cancer SW480 cells [J].Modern Oncology,2020,28(13):2183-2188.
[19] ASHRAFIZADEH M,ZARRABI A,SABERIFAR S,et al.Nobiletin in cancer therapy:how this plant derived-natural compound targets various oncogene and onco-suppressor pathways [J].Biomedicines,2020,8(5):110.
[20] COLLINS R,LEE H,JONES DH,et al.Comparative analysis of small-molecule LIMK1/2 inhibitors:chemical synthesis,biochemistry,and cellular activity [J].J Med Chem,2022,65(20):13705-13713.
[21] 刘鑫慧,杨清.LIMK的研究进展[J].现代肿瘤医学,2018,26(01):137-141.
LIU XH,YANG Q.Research progress of LIMK[J].Modern Oncology,2018,26(01):137-141.
[22] HANKE T,MATHEA S,WOORTMAN J,et al.Development and characterization of type I,type II,and type iII LIM-kinase chemical probes [J].J Med Chem,2022,65(19):13264-13287.
[23] KANG X,LI W,LIU W,et al.LIMK1 promotes peritoneal metastasis of gastric cancer and is a therapeutic target [J].Oncogene,2021,40(19):3422-3433.
[24] ZHANG M,WANG R,TIAN J,et al.Targeting LIMK1 with luteolin inhibits the growth of lung cancer in vitro and in vivo [J].J Cell Mol Med,2021,25(12):5560-5571.
[25] XU S,HUANG H,TANG D,et al.Diallyl disulfide attenuates ionizing radiation-induced migration and invasion by suppressing Nrf2 signaling in non-small-cell lung cancer [J].Dose Response,2021,19(3):15593258211033114.
[26] SU J,HE H,LI Y,et al.Diallyl disulfide inhibits cell proliferation,epithelial-mesenchymal transition,and invasion through RORα-mediated downregulation of Wnt/β-catenin pathway in gastric cancer cells [J].J Food Drug Anal,2022,30(3):479-492.
[27] SU J,ZHOU Y,PAN Z,et al.Downregulation of LIMK1-ADF/cofilin by DADS inhibits the migration and invasion of colon cancer [J].Sci Rep,2017,7:45624.
[28] SU B,SU J,ZENG Y,et al.Diallyl disulfide inhibits TGF β1 induced upregulation of Rac1 and β catenin in epithelial mesenchymal transition and tumor growth of gastric cancer [J].Oncol Rep,2018,39(6):2797-2806.